These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10024024)

  • 1. Structural and chemical complementarity between antibodies and the crystal surfaces they recognize.
    Kessler N; Perl-Treves D; Addadi L; Eisenstein M
    Proteins; 1999 Feb; 34(3):383-94. PubMed ID: 10024024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two and three-dimensional pattern recognition of organized surfaces by specific antibodies.
    Addadi L; Rubin N; Scheffer L; Ziblat R
    Acc Chem Res; 2008 Feb; 41(2):254-64. PubMed ID: 18217721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pH-dependent structural variation of complementarity-determining region H3 in the crystal structures of the Fv fragment from an anti-dansyl monoclonal antibody.
    Nakasako M; Takahashi H; Shimba N; Shimada I; Arata Y
    J Mol Biol; 1999 Aug; 291(1):117-34. PubMed ID: 10438610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that specifically recognize crystals of dinitrobenzene.
    Kessler N; Perl-Treves D; Addadi L
    FASEB J; 1996 Oct; 10(12):1435-42. PubMed ID: 8903514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody recognition of cholesterol monohydrate crystal faces.
    Perl-Treves D; Kessler N; Izhaky D; Addadi L
    Chem Biol; 1996 Jul; 3(7):567-77. PubMed ID: 8807889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins.
    Navazza V; Gabba S; Alfieri A; Giorgetti S; Marchese L; Palladini G; Mattevi A; Ascari E; Caporali R; Montecucco C; Merlini G; Perfetti V
    Mol Immunol; 2008 Mar; 45(5):1519-24. PubMed ID: 17949814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies.
    Rahman A; Haley J; Radway-Bright E; Nagl S; Low DG; Latchman DS; Isenberg DA
    J Mol Biol; 2001 Mar; 307(1):149-60. PubMed ID: 11243810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants in the sequences of immunoglobulin variable domain.
    Chothia C; Gelfand I; Kister A
    J Mol Biol; 1998 May; 278(2):457-79. PubMed ID: 9571064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein.
    Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD
    Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody recognition of chiral surfaces. Structural models of antibody complexes with leucine-leucine-tyrosine crystal surfaces.
    Geva M; Eisenstein M; Addadi L
    Proteins; 2004 Jun; 55(4):862-73. PubMed ID: 15146485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope.
    Li Y; Parry G; Chen L; Callahan JA; Shaw DE; Meehan EJ; Mazar AP; Huang M
    J Mol Biol; 2007 Jan; 365(4):1117-29. PubMed ID: 17101149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNA.
    Herkel J; Kam N; Erez N; Mimran A; Heifetz A; Eisenstein M; Rotter V; Cohen IR
    Eur J Immunol; 2004 Dec; 34(12):3623-32. PubMed ID: 15495163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
    Magdelaine-Beuzelin C; Kaas Q; Wehbi V; Ohresser M; Jefferis R; Lefranc MP; Watier H
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):210-25. PubMed ID: 17624800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.